LobbyingProtecting Access To Pain Relief Coalition lobbying by quarter
Protecting Access To Pain Relief Coalition's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $240K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Protecting Access To Pain Relief Coalition
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $240K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $120K | 1 |
| Q1 2023 | $120K | 1 |
| Q2 2023 | $120K | 1 |
| Q3 2023 | $120K | 1 |
| Q4 2023 | $120K | 1 |
| Q1 2024 | $120K | 1 |
| Q2 2024 | $120K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $80K | 1 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $80K | 1 |
| Q4 2025 | $80K | 1 |
| Q1 2026 | $80K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$980K · 15 reports
- Budget and appropriations$500K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Disease Control & Prevention (CDC)12 reports
- Food & Drug Administration (FDA)3 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $1.5M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| SARAH STARLING CROSSAN | Staff Assistant, Sen. Lamar Alexander; Professional Staff, Health, Education, Labor, and Pensions (HELP) Cmte.; Legislative Correspondent, Sen. Lamar Alexande | Q3 2025 |
| PARKER REYNOLDS | Staff Assistant, Rep. Martha Roby; Staff Assistant, House Republican Conference; Legislative Aide, Senior Legislative Assistant, Rep. Liz Cheney | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Holland & Knight | $80K |
| 04/17for Q1 | Holland & Knight | $80K |
| 01/11for Q4 2025 | Holland & Knight | $80K |
| 25/10/18for Q3 2025 | Holland & Knight | $80K |
| 25/07/04for Q2 2025 | Holland & Knight | $80K |
| 25/04/13for Q1 2025 | Holland & Knight | $80K |
| 25/01/11for Q4 2024 | Holland & Knight | $80K |
| 24/10/09for Q3 2024 | Holland & Knight | $80K |
| 24/07/19for Q2 2024 | Holland & Knight | $120K |
| 24/04/14for Q1 2024 | Holland & Knight | $120K |
| 24/01/13for Q4 2023 | Holland & Knight | $120K |
| 23/10/13for Q3 2023 | Holland & Knight | $120K |
| 23/07/12for Q2 2023 | Holland & Knight | $120K |
| 23/04/12for Q1 2023 | Holland & Knight | $120K |
| 23/01/18for Q4 2022 | Holland & Knight | $120K |